SHA:600129 Market Cap

SHA:600129 has a market cap or net worth of 8.58 billion as of April 29, 2026. Its market cap has decreased by -26.49% in one year.

Market Cap

8.58B

Enterprise Value

12.98B

Revenue

10.20B

Ranking

n/a

PE Ratio

75.45

Stock Price

15.56

Market Cap Chart

Since January 2, 2001, SHA:600129's market cap has increased from 6.65B to 8.58B, an increase of 29.10%. That is a compound annual growth rate of 1.01%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	8.55B	-14.07%
Dec 31, 2025	9.95B	-27.70%
Dec 31, 2024	13.77B	-46.79%
Dec 29, 2023	25.87B	54.56%
Dec 30, 2022	16.74B	33.84%
Dec 31, 2021	12.51B	68.49%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Frontier Biotechnologies	8.52B
Zhejiang Xianju Pharmaceutical	8.76B
Shandong Lukang Pharmaceutical	8.45B
HARBIN GLORIA PHARMACEUTICALS Co., LTD	8.41B
Shenzhen Neptunus Bioengineering	8.39B
Hunan Er-Kang Pharmaceutical	8.37B
Jiuzhitang	8.33B
North China Pharmaceutical Company.Ltd	8.96B

Market Cap Rankings